Harvard Apparatus Regenerative Tech Inc. (HRGN)

[hondobud]

Well I think it was oversold because of finance and change of direction announcement at CC. Continuing down the replacement esophagi road has not changed and they will get their special status and incentives from the FDA for the babies that need transplants. This group of patients will be a good test group, imo. The chart looks good on slow n steady rise. Looks like .33 resistance gave way, I would like to see the trend continue at least above .36 where the big drop found first support. Last CFI insider buy was at .37
So we are awaiting news and imo it will be the FDA green lighting an infant study. When? IDK. But I am sure it will be a PPS stimulant.